v3.26.1
Earnings Per Common Share Attributable to Pfizer Inc. Common Shareholders (Tables)
 3 Months Ended
Mar. 29, 2026
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Earnings Per Share
The following presents the detailed calculation of EPS:
 Three Months Ended
(MILLIONS)March 29,
2026		March 30,
2025
EPS Numerator
Income from continuing operations attributable to Pfizer Inc. common shareholders$2,701 $2,967 
Discontinued operations––net of tax(13)— 
Net income attributable to Pfizer Inc. common shareholders$2,687 $2,967 
EPS Denominator  
Weighted-average number of common shares outstanding––Basic5,691 5,675 
Common-share equivalents40 36 
Weighted-average number of common shares outstanding––Diluted5,731 5,710 
Anti-dilutive common stock equivalents(a)
11 17 
(a)These common stock equivalents were outstanding for the periods presented, but were not included in the computation of diluted EPS for those periods because their inclusion would have had an anti-dilutive effect.